当前位置：首页 SCI期刊 SCIE期刊生物学中科院3区 JCRQ3 期刊介绍(非官网)

Cell Biology InternationalSCIE

国际简称：CELL BIOL INT 参考译名：国际细胞生物学

中科院分区
3区
CiteScore分区
Q2
JCR分区
Q3

基本信息：: ISSN：1065-6995; E-ISSN：1095-8355; 是否OA：未开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：ENGLAND; 出版商：Wiley-Blackwell; 出版语言：English; 出版周期：Monthly; 出版年份：1993; 研究方向：生物-细胞生物学

评价信息：: 影响因子：3.3; H-index：70; CiteScore指数：7.6; SJR指数：0.847; SNIP指数：0.637

发文数据：: Gold OA文章占比：7.36%; 研究类文章占比：81.20%; 年发文量：117; 自引率：0; 开源占比：0.0466; 出版撤稿占比：0; 出版国人文章占比：0.5; OA被引用占比：0.0672...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Cell Biology International期刊介绍

Each month, the journal publishes easy-to-assimilate, up-to-the minute reports of experimental findings by researchers using a wide range of the latest techniques. Promoting the aims of cell biologists worldwide, papers reporting on structure and function - especially where they relate to the physiology of the whole cell - are strongly encouraged. Molecular biology is welcome, as long as articles report findings that are seen in the wider context of cell biology. In covering all areas of the cell, the journal is both appealing and accessible to a broad audience. Authors whose papers do not appeal to cell biologists in general because their topic is too specialized (e.g. infectious microbes, protozoology) are recommended to send them to more relevant journals. Papers reporting whole animal studies or work more suited to a medical journal, e.g. histopathological studies or clinical immunology, are unlikely to be accepted, unless they are fully focused on some important cellular aspect.

These last remarks extend particularly to papers on cancer. Unless firmly based on some deeper cellular or molecular biological principle, papers that are highly specialized in this field, with limited appeal to cell biologists at large, should be directed towards journals devoted to cancer, there being very many from which to choose.

期刊简介Cell Biology International期刊介绍

《Cell Biology International》自1993出版以来，是一本生物学优秀杂志。致力于发表原创科学研究结果，并为生物学各个领域的原创研究提供一个展示平台，以促进生物学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道生物学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：约1.0个月
生物学
CELL BIOLOGY
SCIE
中科院3区
非预警

Cite Score数据（2024年最新版）Cell Biology International Cite Score数据

CiteScore：7.6
SJR：0.847
SNIP：0.637

学科类别	分区	排名	百分位
大类：Biochemistry, Genetics and Molecular Biology 小类：Cell Biology	Q2	111 / 285	61%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Cell Biology International 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
生物学	3区	CELL BIOLOGY 细胞生物学	4区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Cell Biology International JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：CELL BIOLOGY	SCIE	Q3	117 / 205	43.2%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CELL BIOLOGY	SCIE	Q3	146 / 205	29.02%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
CHINA MAINLAND357
Brazil52
Iran41
India35
USA35
Japan28
Ukraine23
Poland13
South Korea11
Russia9

本刊中国学者近年发表论文

1、PLAU contributes to the development of cholangiocarcinoma via activating NF-kappa B signaling pathway
Author: Hu, Mei-Di; Jia, Ling-Hua; Wang, Ming-long

Journal: CELL BIOLOGY INTERNATIONAL. 2023; Vol. , Issue , pp. -. DOI: 10.1002/cbin.12025
2、Tiny Drosophila intestinal stem cells, big power
Author: Zhai, Jingbo; Li, Wanyang; Liu, Xin; Wang, Di; Zhang, Dongli; Liu, Yanli; Liang, Xiuwen; Chen, Zeliang

Journal: CELL BIOLOGY INTERNATIONAL. 2023; Vol. 47, Issue 1, pp. 3-14. DOI: 10.1002/cbin.11911
3、Diagnostic ultrasound-mediated microbubble cavitation dose-dependently improves diabetic cardiomyopathy through angiogenesis
Author: Zhou, Nan-Qian; Song, Yu-Ting; Liu, Wei-Zhen; Yue, Rui-Zhu; Tian, Xin-Qiao; Yang, Shi-Chang; Yin, Ya-Ling; Li, Peng

Journal: CELL BIOLOGY INTERNATIONAL. 2023; Vol. 47, Issue 1, pp. 178-187. DOI: 10.1002/cbin.11918
4、HELQ suppresses migration and proliferation of non-small cell lung cancer cells by repairing DNA damage and inducing necrosis
Author: Zhong, Nan Shan; Tong, Wei Lai; Zhang, Yu; Xiao, Shi Ning; Liu, Jia Ming; Li, An An; Yao, Ge Liang; Lin, Qing; Liu, Zhi Li

Journal: CELL BIOLOGY INTERNATIONAL. 2023; Vol. 47, Issue 1, pp. 188-200. DOI: 10.1002/cbin.11922
5、The diagnostic and prognostic value of pseudogene SIGLEC17P in lung adenocarcinoma and a preliminary functional study
Author: Shen, Xiuqing; Zeng, Yanfen; Yang, Caihong; Jiang, Lili; Chen, Shaoting; Chen, Falin; Cao, Pengju

Journal: CELL BIOLOGY INTERNATIONAL. 2023; Vol. 47, Issue 1, pp. 86-97. DOI: 10.1002/cbin.11919
6、Retinoic acid receptor gamma is required for proliferation of pancreatic cancer cells
Author: Ji, Kaiyuan; Dou, Wenlong; Zhang, Ningfang; Wen, Bolun; Zhong, Mingyan; Zhang, Qianbing; Xu, Shuxiang; Zhou, Jianlong; Liu, Jingfeng

Journal: CELL BIOLOGY INTERNATIONAL. 2023; Vol. 47, Issue 1, pp. 144-155. DOI: 10.1002/cbin.11917
7、Zoledronate promotes osteoblast differentiation in high-glucose conditions via the p38MAPK pathway
Author: Gu, Yingying; Hou, Tian; Qin, Yazhi; Dong, Wei

Journal: CELL BIOLOGY INTERNATIONAL. 2023; Vol. 47, Issue 1, pp. 216-227. DOI: 10.1002/cbin.11921
8、The role of DDX46 in breast cancer proliferation and invasiveness: A potential therapeutic target
Author: Ma, Zhongliang; Song, Jinlian; Hua, Yanan; Wang, Yu; Cao, Weihong; Wang, Haibo; Hou, Lin

Journal: CELL BIOLOGY INTERNATIONAL. 2023; Vol. 47, Issue 1, pp. 283-291. DOI: 10.1002/cbin.11930